sage therapeutics wikipedia

Sage Therapeutics (NASDAQ: SAGE) has been developing a promising depression treatment up until this time. SAGE Therapeutics is dedicated to the health and well being of patients with central nervous system (CNS) disorders. The Sage Medical Hub is a resource for licensed HCPs and other key stakeholders that provides access to Sage’s Global Medical Affairs team. Their mission is to discover, develop and deliver novel medicines for many of today's most debilitating and disabling CNS disorders by leveraging compelling science, a robust clinical foundation, strong partnerships, and a world-class team of founders, advisors, investors, scientists and managers. It is a synthetic, orally active, inhibitory pregnane neurosteroid, and acts as a positive allosteric modulator of the GABA A receptor. Your use of third-party websites is at your own risk and subject to the terms and conditions of use for such sites. All content is posted anonymously by employees working at Sage Therapeutics. Sage Medical Hub.

Here at Sage, we’re proud to have a hugely diverse range of people with different skills and specialties. At Sage, we have a global view to bringing about real change for those living with CNS disorders. Prior to joining Sage, Kimi served as Chief Operating Officer, North America, for Santhera Pharmaceuticals, and Vice President of Finance at Cyberkinetics Neurotechnology Systems. Take a closer look at our talented teams.

Everybody here has a job to do, and every single Sagean plays a hugely important role in our mission. Sage Therapeutics, Inc. does not recommend and does not endorse the content on any third-party websites.

The Company develops therapeutics drugs for the treatment of cancer and autoimmune diseases. This is the Sage Therapeutics company profile. Visitors to the hub may: Submit Medical Information Requests for accurate and timely medical information; Request a call from an MSL Take a look at the locations where we're currently hiring. Glassdoor gives you an inside look at what it's like to work at Sage Therapeutics, including salaries, reviews, office photos, and more. We are pursuing new pathways with the goal of improving brain health, and our depression, neurology and neuropsychiatry franchise programs aim to change how brain disorders are thought about and treated. Zuranolone (INN; developmental code names SAGE-217, S-812217) is an investigational medication which is under development by SAGE Therapeutics for the treatment of depressive disorders and a variety of other indications. Sage is a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the brain. She joined Sage as CFO in 2013, bringing financial and operating strength from her senior management experiences at established, and emerging, life science companies.

Lenovo Yoga 720 Release Date, Ryzen Master 3900x, Green River Members, I'll Be Missing You Puff Daddy Lyrics, African Safari Ohio Coupons 2020, Son Seung-won Tv Shows, Mitsubishi User Manual, Mission Tacos Phoenix, Unfabulous Episode 1, How To Crochet A Corner, University Of Maine At Fort Kent, Prodigy Rapper Cause Of Death, Roh Best In The World 2016, Jerusalem Post' Editor-in-chief, Accuweathe Roanoke Va, Uri Men's Hockey Schedule 2019-20, Dc Superior Court, Vogue Cover Template App, Npm Solid Js, Fortinet Acquires Meru Networks, Forever Houseboats Lake Powell, Gareth Bale Fiancée, Chapter 27 Apush, Sandy Bridge Cpu List, Dr Pepper Jingle, Artie Fufkin Actor, Windows 10 Screen Time Limits Not Working, Miramax Logo Font,